Device Fluid Systems

Fluid Sys - Plasma-Lyte

Payments companies reported to CMS as associated with Fluid Sys - Plasma-Lyte. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$6,947associated payments (2023-2025)
18clinicians with associated payments
1company reporting

By year

2023 $6,947

Payments reported as associated with Fluid Sys - Plasma-Lyte, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Emergency Medicine $3,598
Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,233
Critical Care Medicine (Internal Medicine) $659
Critical Care Medicine (Anesthesiology) $477
Anesthesiology $423
Hospitalist $235

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Fluid Sys - Plasma-Lyte

These are the largest totals companies reported as associated with Fluid Sys - Plasma-Lyte. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Wesley Self Nashville, TN Emergency Medicine $3,105.00
Dimitrios Tsirigotis Gainesville, GA Thoracic Surgery (Cardiothoracic Vascular Surgery) $398.00
Hartmuth Bittner Lafayette, IN Thoracic Surgery (Cardiothoracic Vascular Surgery) $389.00
Robyn Anderson Silver Spring, MD Critical Care Medicine (Internal Medicine) $353.00
Kees Polderman Pittsburgh, PA Critical Care Medicine (Anesthesiology) $310.00
Jeenah Jung Dearborn, MI Thoracic Surgery (Cardiothoracic Vascular Surgery) $286.00
Thomas Cranmer Oak Lawn, IL Emergency Medicine $285.00
Chengda Zhang Portland, OR Hospitalist $235.00
Chirag Chaudhari Glen Burnie, MD Emergency Medicine $208.00
Jacob Kessen Kansas City, KS Nurse Anesthetist, Certified Registered $207.00

Prescribed Fluid Sys - Plasma-Lyte?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.